ArticleFrontiers in psychiatry2025
Ultra-processed food addiction symptoms profile according to weight status among Brazilian adults.
Article in Frontiers in psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: The study aimed to investigate several ultra-processed food (UPF) addiction symptoms according to the weight status and to verify if there are specific symptoms of UPF addiction that differ according to the weight status in adults with a UPF addiction diagnosis. Methods: This is a cross-sectional study that included adults (18-59 years) of both sexes with UPF addiction diagnosis. Demographic and clinical data were collected, such as body mass index (BMI), diagnosis of depression, and generalized anxiety disorder (GAD). UPF addiction was assessed using the modified Yale Food Addiction Scale 2.0. Results: In total, 1,074 participants were included. Of this total, 83.3% (n = 895) were female, with a mean age of 23 ± 5 years, of which 36.8% (n = 395) were classified with normal weight, 31.9% (n = 343) with overweight, 19.5% (n = 209) with obesity I, 8.1% (n = 87) with obesity II, and 3.7% (n = 40) with obesity III. The prevalence of UPF addiction symptoms referring to social/interpersonal harm, cut down/quit, role interference, and physical/psychological harm increased progressively with increasing BMI, even after adjusting for age, sex, diagnosis of depression, and GAD. Conclusion: This study showed a progressive increase in UPF addiction symptom severity with rising BMI levels. Moreover, distinct UPF addiction symptom profiles emerged across various BMI categories. Understanding these nuances can guide the development of targeted interventions and treatment strategies to address this multifaceted behavioral profile effectively. Further research across different populations is imperative to broaden our comprehension of UPF addiction's impact and expression.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.